
#1231Medicine & HealthFront Page1 January 2026
Re-evaluating Clinical Trial Eligibility Criteria: Are We Excluding Viable Patients?
A retrospective analysis suggests that rigid exclusion protocols may bar nearly 14% of otherwise suitable cancer patients from clinical trials. The study highlights borderline laboratory abnormalities as a primary driver of these potentially modifiable exclusions.
By Saj, Namayanja, Xiao, Borad, Kelley, Goyal, Azad, Bachini, Lindsey, Pant, Valle, Fashoyin‐Aje, Javle